Nervonik announced today that it closed an oversubscribed Series B financing round worth proceeds of $52.5 million.
But if your legs ache every time you walk, it could be peripheral artery disease (PAD). Here we break down what the condition ...
Nepal: Pyoderma gangrenosum (PG) can occur without associated systemic disease and may resemble infectious or vascular ulcers ...
Stryker has signed an agreement to acquire Amplitude Vascular Systems, adding its Pulse intravascular lithotripsy system to the company’s peripheral vascular portfolio. The technology uses pressurized ...
GlobalData on MSN
Stryker agrees to acquire IVL developer Amplitude Vascular Systems
Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.
Nervonik raises $52.5M in Series B funding to advance its peripheral nerve stimulation technology and expand innovative ...
This case-based haematology learning module explores five common but often challenging scenarios arising with abnormal full ...
A 2026 product overview of how RevivaFlow Foot is described for burning feet, tingling, and circulation support - covering ...
There are evenings that simply host guests--and then there are evenings that capture imagination, command attention, and announce the arrival of something extraordinary. The recent celebration of the ...
Self-adhesive polymer substrates turn independently optimized transistor modules into snap-together electronic skin that ...
Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS).
Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results